NYSE - Nasdaq Real Time Price USD

Medtronic plc (MDT)

79.22 -1.16 (-1.44%)
As of 2:57 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
4/30/2023
4/30/2022
4/30/2021
4/30/2020
Total Revenue
32,320,000.00
31,227,000.00
31,686,000.00
30,117,000.00
28,913,000.00
Cost of Revenue
11,151,000.00
10,719,000.00
10,145,000.00
10,483,000.00
9,424,000.00
Gross Profit
21,169,000.00
20,508,000.00
21,541,000.00
19,634,000.00
19,489,000.00
Operating Expense
15,028,000.00
14,678,000.00
15,633,000.00
14,739,000.00
14,267,000.00
Operating Income
6,141,000.00
5,830,000.00
5,908,000.00
4,895,000.00
5,222,000.00
Net Non Operating Interest Income Expense
-704,000.00
-636,000.00
-553,000.00
-925,000.00
-1,092,000.00
Other Income Expense
97,000.00
170,000.00
163,000.00
-75,000.00
-75,000.00
Pretax Income
5,533,000.00
5,364,000.00
5,517,000.00
3,895,000.00
4,055,000.00
Tax Provision
1,298,000.00
1,580,000.00
456,000.00
265,000.00
-751,000.00
Net Income Common Stockholders
4,201,000.00
3,758,000.00
5,039,000.00
3,606,000.00
4,789,000.00
Diluted NI Available to Com Stockholders
4,201,000.00
3,758,000.00
5,039,000.00
3,606,000.00
4,789,000.00
Basic EPS
3.16
2.83
3.75
2.68
3.57
Diluted EPS
3.15
2.82
3.73
2.66
3.54
Basic Average Shares
1,330,175.00
1,329,800.00
1,342,400.00
1,344,900.00
1,340,700.00
Diluted Average Shares
1,332,500.00
1,332,800.00
1,351,400.00
1,354,000.00
1,351,100.00
Total Operating Income as Reported
5,656,000.00
5,485,000.00
5,752,000.00
4,484,000.00
4,791,000.00
Total Expenses
26,179,000.00
25,397,000.00
25,778,000.00
25,222,000.00
23,691,000.00
Net Income from Continuing & Discontinued Operation
4,201,000.00
3,758,000.00
5,039,000.00
3,606,000.00
4,789,000.00
Normalized Income
4,570,691.85
4,001,225.00
5,181,135.00
3,989,037.23
5,103,630.00
Interest Expense
704,000.00
636,000.00
553,000.00
925,000.00
1,092,000.00
Net Interest Income
-704,000.00
-636,000.00
-553,000.00
-925,000.00
-1,092,000.00
EBIT
6,237,000.00
6,000,000.00
6,070,000.00
4,820,000.00
5,147,000.00
EBITDA
8,909,000.00
8,697,000.00
8,777,000.00
7,522,000.00
7,810,000.00
Reconciled Cost of Revenue
10,176,000.00
9,720,000.00
9,171,000.00
9,564,000.00
8,517,000.00
Reconciled Depreciation
2,672,000.00
2,697,000.00
2,707,000.00
2,702,000.00
2,663,000.00
Net Income from Continuing Operation Net Minority Interest
4,201,000.00
3,758,000.00
5,039,000.00
3,606,000.00
4,789,000.00
Total Unusual Items Excluding Goodwill
-483,000.00
-345,000.00
-155,000.00
-411,000.00
-431,000.00
Total Unusual Items
-483,000.00
-345,000.00
-155,000.00
-411,000.00
-431,000.00
Normalized EBITDA
9,392,000.00
9,042,000.00
8,932,000.00
7,933,000.00
8,241,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-113,308.15
-101,775.00
-12,865.00
-27,962.77
-116,370.00
4/30/2020 - 5/2/1973

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABT Abbott Laboratories
106.72
-0.16%
 
BSX Boston Scientific Corporation
73.24
+0.45%
 
SYK Stryker Corporation
336.60
-0.07%
 
EW Edwards Lifesciences Corporation
88.22
-0.44%
 
DXCM DexCom, Inc.
138.05
+0.13%
 
ZBH Zimmer Biomet Holdings, Inc.
119.58
-1.31%
 
ALGN Align Technology, Inc.
307.71
-1.93%
 
SWAV Shockwave Medical, Inc.
329.32
+0.14%
 
INMD InMode Ltd.
16.99
-2.13%
 
PODD Insulet Corporation
163.25
-2.39%